Charles River launches nAAVigation Vector Platform, with the capability to reduce viral vector gene therapy program timelines to GMP by 55%.

But he says it’s possible to gather more information to include on future maps. “To be a useful hydrography map, it should have information on river volume, size, seasonality, etc,” he said.

Charles River Laboratories International announced the launch of its off-the-shelf replication/capsid (rep/cap) plasmids for the manufacture of adeno-associated virus (AAV) vectors during Advanced ...

New Business Models for Manufacturing Investment - Wednesday, October 12, 3:15pm – 4:15pm PST Join Charles River for three days of partnering and industry updates on clinical trial design, alternative ...